首药控股（北京）股份有限公司2025年半年度报告摘要

Core Points - The company has announced changes to its registered address, the cancellation of its supervisory board, and amendments to its articles of association [4][5][6] - The board of directors has confirmed the accuracy and completeness of the announcement, ensuring no misleading statements or omissions [4][6] - The company will no longer have a supervisory board, with the audit committee taking over its responsibilities in accordance with the revised Company Law and relevant regulations [5][6] Group 1: Company Changes - The registered address will be changed from "Building A, 22nd Floor, No. 10 Ronghua Middle Road, Beijing Economic and Technological Development Zone" to "Unit 2202-2, 19th Floor, No. 10 Ronghua Middle Road, Beijing Economic and Technological Development Zone" [4] - The supervisory board will be abolished, and its functions will be assumed by the audit committee, in line with the latest legal requirements [5][6] - The articles of association will be systematically revised to improve the governance structure, including the removal of references to the supervisory board and its members [6][7] Group 2: Governance and Compliance - The company will ensure compliance with the revised Company Law and the Shanghai Stock Exchange's listing rules [5][6] - The board has expressed gratitude to the outgoing supervisory board members for their contributions during their tenure [6] - The management is authorized to handle the necessary business registration changes and document signing related to these amendments [7]